INS and hyperuricemia: The potential value of eGDR as a simple, non-fasting metric requiring only basic clinical parameters-which could serve as a robust insulin sensitivity marker particularly advantageous for large-scale epidemiological studies and hyperuricemia risk stratification in diverse populations-remains insufficiently investigated.